Clover Health Investments, Corp. (CLOV) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 1 recommend buying, 5 recommend holding, and 3 recommend selling.
The analyst consensus price target for CLOV is $3.00, representing a +47.1% upside from the current price of $2.04. Price targets range from a low of $3.00 to a high of $3.00.
